Methodology Study To Examine 6-Week Food Intake With Liraglutide In Obese Subjects
Status: | Completed |
---|---|
Conditions: | Obesity Weight Loss |
Therapuetic Areas: | Endocrinology |
Healthy: | No |
Age Range: | 18 - 75 |
Updated: | 2/11/2018 |
Start Date: | February 20, 2017 |
End Date: | January 16, 2018 |
A 6-week, Randomized, Double-blind, Placebo-controlled, Two-arm, Parallel Methodology Study To Assess The Effect Of Liraglutide On Food Intake In Obese Subjects
This will be a randomized, double blind, placebo controlled, 2 arm, parallel group,
methodology study to assess the effect of 6 weeks of liraglutide administration on food
intake in obese subjects.
methodology study to assess the effect of 6 weeks of liraglutide administration on food
intake in obese subjects.
Inclusion Criteria:
- Males and female subjects;
- Body Mass Index 30-40 kg/m2;
Exclusion Criteria:
- Evidence of history of clinically significant hematological, renal, endocrine,
pulmonary, gastrointestinal, cardiovascular, hepatic, psychiatric, neurologic, or
allergic disease (including drug allergises, but excluding untreated, asymptomatic,
seasonal allergies at time of dosing)
We found this trial at
1
site
Click here to add this to my saved trials